Elaprase Solution, Concentrate
Product Images NDC 54092-700

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Elaprase (NDC 54092-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (6 mg/3 mL Vial Carton)

Packaging label for ELAPRASE (idursulfase) injection, 6 mg/3 mL (2 mg/mL), a solution concentrate for intravenous infusion. The label indicates a single use vial with instructions to discard unused portions and notes that the product must be diluted for intravenous infusion. It includes the Takeda Pharmaceuticals America, Inc. logo, storage instructions, a barcode, contact information, and legal/trademark details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.